# US 2025/0152649 A1 · Pharmaceutical composition for use in increasing hair, modifying scalp or skin, healing a wound, promoting osteogenesis, or modifying hair

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0152649 A1
- Document ID: US20250152649A1
- Status: Published application
- Kind: A1
- Application number: 19/026,822
- Filed: 2025-01-17
- Published: 2025-05-15
- Earliest claimed: 2017-12-26
- Inventors: Hirotaro FUKUOKA
- Web page: https://patentgrep.com/patent/US20250152649A1

## CPC

- A61K 36/48: Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K 8/361: {Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof}
- A61K 8/922: {of vegetable origin}
- A61K 8/9789: Magnoliopsida [dicotyledons]
- A61K 8/986: {Milk; Derivatives thereof, e.g. butter}
- A61K 9/0014: {Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00)}
- A61K 9/08: Solutions {(composition of solutions A61K47/00)}
- A61K 9/107: Emulsions {; Emulsion preconcentrates; Micelles (composition of emulsions A61K47/00)}
- A61K 9/7007: {Drug-containing films, membranes or sheets (A61K9/0041, A61K9/0043, A61K9/006, A61K9/0063 take precedence)}
- A61K 9/7015: {Drug-containing film-forming compositions, e.g. spray-on}
- A61K 31/20: having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K 31/201: having one or two double bonds, e.g. oleic, linoleic acids
- A61K 35/20: Milk; Whey; Colostrum
- A61K 47/46: Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
- A61P 17/00: Drugs for dermatological disorders
- A61P 17/02: for treating wounds, ulcers, burns, scars, keloids, or the like
- A61P 17/14: for baldness or alopecia
- A61P 19/00: Drugs for skeletal disorders
- A61P 19/10: for osteoporosis
- A61Q 5/00: Preparations for care of the hair
- A61Q 7/00: Preparations for affecting hair growth
- A61Q 19/00: Preparations for care of the skin
- A61K 2800/91: Injection
- A61Q 5/10: Preparations for permanently dyeing the hair
- A61Q 19/08: Anti-ageing preparations
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

The present invention provides a pharmaceutical composition for use in increasing hair, modifying scalp or skin, healing a wound, promoting osteogenesis or modifying hair, the pharmaceutical composition comprising a therapeutically effective amount of a saturated fatty acid or a pharmaceutically acceptable salt thereof as an active ingredient.

## Claims

### Claim 1

A method for tissue regeneration in a human in need thereof, the method comprising:
intradermally or subcutaneously administrating a pharmaceutical composition to the scalp or to the skin in the human,
wherein the pharmaceutical composition is sterilized and comprises a therapeutically effective amount of a saturated fatty acid or a pharmaceutically acceptable salt thereof, wherein the saturated fatty acid is at least one fatty acid selected from the group consisting of palmitic acid, stearic acid and myristic acid.

### Claim 2 (depends on 1)

The method of claim 1, wherein the pharmaceutical composition comprises palmitic acid.

### Claim 3 (depends on 1)

The method of claim 1, wherein the pharmaceutical composition comprises milk, milk serum, a milk extracted product, a milk processed product or a mixture thereof having a reduced lactoferrin content.

### Claim 4 (depends on 1)

The method of claim 1, wherein the pharmaceutical composition comprises milk, milk serum, a milk extracted product, a milk processed product or a mixture thereof which has been sterilized by heating.

### Claim 5 (depends on 4)

The method of claim 4, wherein the milk, milk serum, milk extracted product, milk processed product or a mixture thereof is from a human.

### Claim 6 (depends on 5)

The method of claim 5, wherein the milk, milk serum, milk extracted product, milk processed product or a mixture thereof is from a colostrum of a woman.

### Claim 7 (depends on 1)

The method of claim 1, wherein the pharmaceutical composition comprises at least one selected from the group consisting of an animal oil, vegetable oil, extracted product, and processed product of the oils, wherein the animal oil, vegetable oil, extracted product, and processed product of the oils comprise at least one fatty acid selected from the group consisting of palmitic acid, stearic acid and myristic acid.

### Claim 8 (depends on 1)

The method of claim 1, wherein the pharmaceutical composition has been lyophilized.

### Claim 9 (depends on 1)

The method of claim 1, wherein the pharmaceutical composition comprises a therapeutically effective amount of the saturated fatty acid, wherein the saturated fatty acid consists of palmitic acid, stearic acid, myristic acid, or a combination thereof.
